Venturi Wealth Management LLC Has $124,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Venturi Wealth Management LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11,345.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,259 shares of the exchange traded fund’s stock after buying an additional 1,248 shares during the period. Venturi Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $124,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. ORG Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $40,000. Quintet Private Bank Europe S.A. bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $40,000. ORG Wealth Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $44,000. Waldron Private Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $54,000. Finally, Resources Management Corp CT ADV increased its stake in shares of SPDR S&P Biotech ETF by 30.3% in the 2nd quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock valued at $55,000 after acquiring an additional 138 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.5 %

Shares of NYSEARCA XBI opened at $100.01 on Thursday. The firm has a market cap of $7.62 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s fifty day simple moving average is $99.07 and its 200 day simple moving average is $95.98. SPDR S&P Biotech ETF has a 12-month low of $69.32 and a 12-month high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.